text: VISA and VRSA cannot be successfully treated with<unk>  because these organisms are no longer susceptibile to<unk> . However, to date, all VISA and VRSA isolates have been susceptible to other Food and Drug Administration (FDA) approved drugs like trimethoprim/sulfamethoxazole, clindamycin, or ceftaroline.
option_0: Vancomycin-resistant Staphylococcus aureus medical therapy
option_1: Staphylococcus aureus infection medical therapy
option_2: Proteus infection medical therapy
option_3: Cutaneous abscess medical therapy
option_4: Endocarditis medical therapy
option_5: Opportunistic infection medical therapy
option_6: Pneumonia medical therapy
option_7: Escherichia coli infection medical therapy